Literature DB >> 6441018

Carnitine balance and effects of intravenous L-carnitine in two patients receiving long-term total parenteral nutrition.

L I Worthley, R C Fishlock, A M Snoswell.   

Abstract

Two patients requiring total parenteral nutrition for 34 and 39 months, had plasma and urinary carnitine assays and plasma lipid assays performed before and during intravenous administration of 400 mg (2500 mumol) of L-carnitine for 7 days, followed by 40 mg (240 mumol) daily continuously. One patient had generalized lethargy and weakness which resolved within the first 5 days of carnitine administration. The plasma-free carnitine levels in this patient rose significantly. The other patient was asymptomatic and while there was no significant change in the plasma-free carnitine levels during carnitine administration, this patient remained in positive carnitine balance throughout the study. There were no significant changes in plasma lipid levels in either patient. In adult patients requiring long-term total parenteral nutrition who are otherwise normal, intravenous L-carnitine may be required to supplement the patients endogenous carnitine production.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6441018     DOI: 10.1177/0148607184008006717

Source DB:  PubMed          Journal:  JPEN J Parenter Enteral Nutr        ISSN: 0148-6071            Impact factor:   4.016


  3 in total

1.  Subnormal carnitine levels and their correction in artificially fed patients from a neurological intensive care unit: a pilot study.

Authors:  J Schäfer; H Reichmann
Journal:  J Neurol       Date:  1990-06       Impact factor: 4.849

Review 2.  l-Carnitine. A preliminary review of its pharmacokinetics, and its therapeutic use in ischaemic cardiac disease and primary and secondary carnitine deficiencies in relationship to its role in fatty acid metabolism.

Authors:  K L Goa; R N Brogden
Journal:  Drugs       Date:  1987-07       Impact factor: 9.546

3.  [Effect of L-carnitine supplemented total parenteral nutrition on postoperative lipid and nitrogen utilization].

Authors:  C Rössle; C Pichard; M Roulet; R Chiolero; Y Schutz; E Temler; C Schindler; F Zurlo; E Jéquier; P Fürst
Journal:  Klin Wochenschr       Date:  1988-12-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.